Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200433, China.
Department of Hepatobiliary and Pancreatic Surgery, Fujian Provincial Hospital, The Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Hepatol Int. 2023 Oct;17(5):1251-1264. doi: 10.1007/s12072-023-10492-2. Epub 2023 Apr 15.
This study aimed at analyzing and comparing the perioperative results and long-term oncological outcomes of hepatocellular carcinoma (HCC) patients with type 2 diabetes mellitus (T2DM) treated with laparoscopic (LLR) versus open liver resection (OLR).
Clinicopathological data of HCC patients with T2DM who underwent LLR or OLR as initial treatment from four medical centers were retrospectively reviewed. The survival outcomes of patients who underwent laparoscopic liver resection (LLR) were compared with those of patients who underwent open liver resection (OLR). Using the Kaplan-Meier method, survival curves for the two groups of patients were generated, and the log-rank test was used to compare survival differences. Propensity score matching (PSM) analysis was used to match patients of the LLR and OLR groups in a 1:1 ratio.
230 HCC patients with T2DM were enrolled, including 101 patients in the LLR group and 129 patients in the OLR group. After PSM, 90 patients were matched in each of the study group. Compared with the OLR group, the LLR group had less blood loss, a shorter hospitalization and fewer postoperative complications. The LLR group had a significantly better overall survival (OS) and recurrence-free survival (RFS) than the OLR group before and after PSM. Subgroup analysis demonstrated that HCC patients with T2DM had survival benefits from LLR regardless of the course of T2DM.
Laparoscopic liver resection for HCC patients with T2DM can be safely performed with favorable perioperative and long-term oncological outcomes at high-volume liver cancer centers, regardless of the course of T2DM.
本研究旨在分析和比较 2 型糖尿病(T2DM)合并肝细胞癌(HCC)患者接受腹腔镜(LLR)与开腹肝切除术(OLR)治疗的围手术期结果和长期肿瘤学结局。
回顾性分析 4 家医疗中心的 T2DM 合并 HCC 患者接受 LLR 或 OLR 初始治疗的临床病理资料。比较接受腹腔镜肝切除术(LLR)和开腹肝切除术(OLR)的患者的生存结果。使用 Kaplan-Meier 法生成两组患者的生存曲线,并使用对数秩检验比较生存差异。采用倾向评分匹配(PSM)分析将 LLR 和 OLR 组的患者以 1:1 的比例匹配。
共纳入 230 例 T2DM 合并 HCC 患者,其中 LLR 组 101 例,OLR 组 129 例。PSM 后,每组匹配 90 例患者。与 OLR 组相比,LLR 组术中出血量较少,住院时间较短,术后并发症较少。在 PSM 前后,LLR 组的总生存期(OS)和无复发生存期(RFS)均显著优于 OLR 组。亚组分析表明,T2DM 合并 HCC 患者在高容量肝癌中心接受 LLR 治疗可获得生存获益,无论 T2DM 病程如何。
对于 T2DM 合并 HCC 的患者,在高容量肝癌中心,无论 T2DM 病程如何,腹腔镜肝切除术都可以安全进行,具有良好的围手术期和长期肿瘤学结局。